<!DOCTYPE html>
<html lang="en" dir="auto">

<head>
<head>
    <title>health informatics</title>
    <meta charset="utf-8">
    <meta name="description"
        content="Website meta description for google search results go here" />
    <meta name="dc.relation" content="https://trxiv.yorks0n.com" />
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta name="theme-color" content="#1A94D2" />

    

    
    
    
    <link rel="stylesheet" href="/css/main.min.css" media="screen">

</head>


<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>health informatics | TRxiv2</title>
<meta name="keywords" content="">
<meta name="description" content="DiabetIA: Building Machine Learning Models for Type 2 Diabetes Complications
Authors: Tripp, J.; Santana-Quinteros, D.; Perez-Estrada, R.; Rodriguez-Moran, M. F.; Arcos-Gonzalez, C.; Mercado-Rios, J.; Cristobal-Perez, F.; Hernandez-Martinez, B. R.; Nava-Aguilar, M. A.; Gonzalez-Arroyo, G.; Salazar-Fernandez, E. P.; Quiroz-Armada, P. S.; Cortes-Vieyra, R.; Noriega-Cisneros, R.; Zinzun-Ixta, G.; Maldonado-Pichardo, M. C.; Flores-Alvarez, L. J.; Reyes-Granados, S. C.; Chagolla-Morales, R.; Paredes-Saralegui, J. G.; Flores-Garrido, M.; Garcia-Velazquez, L. M.; Figueroa-Mora, K. M.; Gomez-Garcia, A.">
<meta name="author" content="">
<link rel="canonical" href="https://trxiv.yorks0n.com/posts/health-informatics/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.904bd1e751cdd2a584fa6bed3fa1166dfd8ec9949ebfd0c4d69c5add5e17c23d.css" integrity="sha256-kEvR51HN0qWE&#43;mvtP6EWbf2OyZSev9DE1pxa3V4Xwj0=" rel="preload stylesheet" as="style">
<script defer crossorigin="anonymous" src="/assets/js/highlight.f413e19d0714851f6474e7ee9632408e58ac146fbdbe62747134bea2fa3415e0.js" integrity="sha256-9BPhnQcUhR9kdOfuljJAjlisFG&#43;9vmJ0cTS&#43;ovo0FeA="
    onload="hljs.initHighlightingOnLoad();"></script>
<link rel="icon" href="https://trxiv.yorks0n.com/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://trxiv.yorks0n.com/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://trxiv.yorks0n.com/favicon-32x32.png">
<link rel="apple-touch-icon" href="https://trxiv.yorks0n.com/apple-touch-icon.png">
<link rel="mask-icon" href="https://trxiv.yorks0n.com/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --hljs-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript><meta property="og:title" content="health informatics" />
<meta property="og:description" content="DiabetIA: Building Machine Learning Models for Type 2 Diabetes Complications
Authors: Tripp, J.; Santana-Quinteros, D.; Perez-Estrada, R.; Rodriguez-Moran, M. F.; Arcos-Gonzalez, C.; Mercado-Rios, J.; Cristobal-Perez, F.; Hernandez-Martinez, B. R.; Nava-Aguilar, M. A.; Gonzalez-Arroyo, G.; Salazar-Fernandez, E. P.; Quiroz-Armada, P. S.; Cortes-Vieyra, R.; Noriega-Cisneros, R.; Zinzun-Ixta, G.; Maldonado-Pichardo, M. C.; Flores-Alvarez, L. J.; Reyes-Granados, S. C.; Chagolla-Morales, R.; Paredes-Saralegui, J. G.; Flores-Garrido, M.; Garcia-Velazquez, L. M.; Figueroa-Mora, K. M.; Gomez-Garcia, A." />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://trxiv.yorks0n.com/posts/health-informatics/" /><meta property="article:section" content="posts" />
<meta property="article:published_time" content="2023-10-29T10:37:40+00:00" />
<meta property="article:modified_time" content="2023-10-29T10:37:40+00:00" />

<meta name="twitter:card" content="summary"/>
<meta name="twitter:title" content="health informatics"/>
<meta name="twitter:description" content="DiabetIA: Building Machine Learning Models for Type 2 Diabetes Complications
Authors: Tripp, J.; Santana-Quinteros, D.; Perez-Estrada, R.; Rodriguez-Moran, M. F.; Arcos-Gonzalez, C.; Mercado-Rios, J.; Cristobal-Perez, F.; Hernandez-Martinez, B. R.; Nava-Aguilar, M. A.; Gonzalez-Arroyo, G.; Salazar-Fernandez, E. P.; Quiroz-Armada, P. S.; Cortes-Vieyra, R.; Noriega-Cisneros, R.; Zinzun-Ixta, G.; Maldonado-Pichardo, M. C.; Flores-Alvarez, L. J.; Reyes-Granados, S. C.; Chagolla-Morales, R.; Paredes-Saralegui, J. G.; Flores-Garrido, M.; Garcia-Velazquez, L. M.; Figueroa-Mora, K. M.; Gomez-Garcia, A."/>


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [, 
    {
      "@type": "ListItem",
      "position":  2 ,
      "name": "Posts",
      "item": "https://trxiv.yorks0n.com/posts/"
    }, 
    {
      "@type": "ListItem",
      "position":  3 ,
      "name": "health informatics",
      "item": "https://trxiv.yorks0n.com/posts/health-informatics/"
    }
  ]
}
</script>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "health informatics",
  "name": "health informatics",
  "description": "DiabetIA: Building Machine Learning Models for Type 2 Diabetes Complications\nAuthors: Tripp, J.; Santana-Quinteros, D.; Perez-Estrada, R.; Rodriguez-Moran, M. F.; Arcos-Gonzalez, C.; Mercado-Rios, J.; Cristobal-Perez, F.; Hernandez-Martinez, B. R.; Nava-Aguilar, M. A.; Gonzalez-Arroyo, G.; Salazar-Fernandez, E. P.; Quiroz-Armada, P. S.; Cortes-Vieyra, R.; Noriega-Cisneros, R.; Zinzun-Ixta, G.; Maldonado-Pichardo, M. C.; Flores-Alvarez, L. J.; Reyes-Granados, S. C.; Chagolla-Morales, R.; Paredes-Saralegui, J. G.; Flores-Garrido, M.; Garcia-Velazquez, L. M.; Figueroa-Mora, K. M.; Gomez-Garcia, A.",
  "keywords": [
    
  ],
  "articleBody": " DiabetIA: Building Machine Learning Models for Type 2 Diabetes Complications\nAuthors: Tripp, J.; Santana-Quinteros, D.; Perez-Estrada, R.; Rodriguez-Moran, M. F.; Arcos-Gonzalez, C.; Mercado-Rios, J.; Cristobal-Perez, F.; Hernandez-Martinez, B. R.; Nava-Aguilar, M. A.; Gonzalez-Arroyo, G.; Salazar-Fernandez, E. P.; Quiroz-Armada, P. S.; Cortes-Vieyra, R.; Noriega-Cisneros, R.; Zinzun-Ixta, G.; Maldonado-Pichardo, M. C.; Flores-Alvarez, L. J.; Reyes-Granados, S. C.; Chagolla-Morales, R.; Paredes-Saralegui, J. G.; Flores-Garrido, M.; Garcia-Velazquez, L. M.; Figueroa-Mora, K. M.; Gomez-Garcia, A.; Alvarez-Aguilar, C.; Lopez-Pineda, A.\nScore: 3.0, Published: 2023-10-23 DOI: 10.1101/2023.10.22.23297277\nBackgroundArtificial intelligence (AI) models applied to diabetes mellitus research have grown in recent years, particularly in the field of medical imaging. However little work has been done exploring real-world data (RWD) sources such as electronic health records (EHR) mostly due to the lack of reliable public diabetes databases. However, with more than 500 million patients affected worldwide, complications of this condition have catastrophic consequences. In this manuscript we aim to first extract, clean and transform a novel diabetes research database, DiabetIA, and secondly train machine learning (ML) models to predict diabetic complications. MethodsIn this study, we used observational retrospective data from the Mexican Institute for Social Security (IMSS) extracting and de-identifying EHR data for almost 2 million patients seen at primary care facilities. After applying eligibility criteria for this study, we constructed a diabetes complications database. Next, we trained naive Bayesian models with various subsets of variables, including an expert-selected model. ResultsThe DiabetIA database is composed of 136,674 patients (414,770 records and 447 variables), with 33,314 presenting diabetes (24.3%). The most frequent diabetic complications were diabetic foot with 2,537 patients, nephropathy with 1,914 patients, retinopathy with 1,829 patients, and neuropathy with 786 patients. These complications were accurately predicted by the Gaussian naive Bayessian models with an average area under the curve AUC of 0.86. Our expert-selected model, achieved an average AUC of 0.84 with 21 curated variables. ConclusionOur study offers the largest longitudinal research database from EHR data in Latin America for research. The DiabetIA database provides a useful resource to estimate the burden of diabetic complications on healthcare systems. Machine learning models can provide accurate estimations of the total cases presented in medical units. For patients and their clinicians, it is imperative to have a way to calculate this risk and start clinical interventions to slow down or prevent the complications of this condition. Brief descriptionThe study centers on establishing the DiabetIA database, a substantial repository encompassing de-identified electronic health records from 136,674 patients sourced from primary care facilities within the Mexican Institute for Social Security (IMSS). Our efforts involved curating, cleansing, and transforming this extensive dataset, and then employing machine learning models to predict diabetic complications with high accuracy.\nClinical performance of automated machine learning: a systematic review\nAuthors: Thirunavukarasu, A. J.; Elangovan, K.; Gutierrez, L.; Hassan, R.; Li, Y.; Tan, T. F.; Cheng, H.; Teo, Z. L.; Lim, G.; Ting, D. S. W.\nScore: 1.2, Published: 2023-10-26 DOI: 10.1101/2023.10.26.23297599\nIntroduction Automated machine learning (autoML) removes technical and technological barriers to building artificial intelligence models. We aimed to summarise the clinical applications of autoML, assess the capabilities of utilised platforms, evaluate the quality of the evidence trialling autoML, and gauge the performance of autoML platforms relative to conventionally developed models, as well as each other. Methods This review adhered to a PROSPERO-registered protocol (CRD42022344427). The Cochrane Library, Embase, MEDLINE, and Scopus were searched from inception to 11 July 2022. Two researchers screened abstracts and full texts, extracted data and conducted quality assessment. Disagreement was resolved through discussion and as-required arbitration by a third researcher. Results In 82 studies, 26 distinct autoML platforms featured. Brain and lung disease were the most common fields of study of 22 specialties. AutoML exhibited variable performance: AUCROC 0.35-1.00, F1-score 0.16-0.99, AUCPR 0.51-1.00. AutoML exhibited the highest AUCROC in 75.6% trials; the highest F1-score in 42.3% trials; and the highest AUCPRC in 83.3% trials. In autoML platform comparisons, AutoPrognosis and Amazon Rekognition performed strongest with unstructured and structured data respectively. Quality of reporting was poor, with a median DECIDE-AI score of 14 of 27. Conclusions A myriad of autoML platforms have been applied in a variety of clinical contexts. The performance of autoML compares well to bespoke computational and clinical benchmarks. Further work is required to improve the quality of validation studies. AutoML may facilitate a transition to data-centric development, and integration with large language models may enable AI to build itself to fulfil user-defined goals.\nToward AI-Guided Smoking Cessation: Individualized Nicotine Addiction Modeling Using Gaussian Processes\nAuthors: Chari, A.\nScore: 1.2, Published: 2023-10-27 DOI: 10.1101/2023.10.25.23297563\nCigarette smoking remains the leading cause of preventable disease and death in the United States, accounting for nearly half a million deaths annually. Given the recent rise of artificial intelligence in healthcare applications, computational assessment of smoking behaviors is a promising direction. In this study, we aim to recognize and classify addiction patterns in individual smokers' daily usage based on time series data. To this end, we leverage Gaussian process modeling to iteratively learn a function that defines a smoker's behavior as usage data is accumulated. Namely, we aim to learn weekly periodic trends in usage, and then utilize the model to predict future trends. We demonstrate that the outputted predictions resemble the actual data well and that these informed forecasts significantly outperform those of a naive prediction model with respect to accuracy. Finally, we propose strategies for utilizing these predictions for goal-setting as part of a computer-supervised gradual cessation program.\nFDA approved Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices: An updated landscape\nAuthors: Joshi, G.; Jain, A.; Araveeti, S. R.; Adhikari, S.; Garg, H.; Bhandari, M.\nScore: 3.0, Published: 2023-10-23 DOI: 10.1101/2022.12.07.22283216\nAs artificial intelligence (AI) has been highly advancing in the last decade, machine learning (ML) enabled medical devices are increasingly used in healthcare. In this article, we performed comprehensive analysis of FDA approved Artificial Intelligence and Machine Learning (AI/ML)- Enabled Medical Devices and offer an in-depth analysis of clearance pathways, approval timeline, regulation type, medical specialty, decision type, recall history etc. We found a significant surge in approvals since 2018, with clear dominance of radiology specialty in the application of machine learning tools, attributed to the abundant data from routine clinical data. The study also reveals a reliance on the 510(k)-clearance pathway, emphasizing its basis on substantial equivalence and often bypassing the need for new clinical trials. Also, it notes an underrepresentation of pediatric- focused devices and trials, suggesting an opportunity for expansion in this demographic. Moreover, the geographical limitation of clinical trials, primarily within the United States, points to a need for more globally inclusive trails to encompass diverse patient demographics. This analysis not only maps the current landscape of AI/ML-Enabled Medical Devices but also pinpoints trends, potential gaps, and areas for future exploration, clinical trial practices, and regulatory approaches.\n",
  "wordCount" : "1127",
  "inLanguage": "en",
  "datePublished": "2023-10-29T10:37:40Z",
  "dateModified": "2023-10-29T10:37:40Z",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://trxiv.yorks0n.com/posts/health-informatics/"
  },
  "publisher": {
    "@type": "Organization",
    "name": "TRxiv2",
    "logo": {
      "@type": "ImageObject",
      "url": "https://trxiv.yorks0n.com/favicon.ico"
    }
  }
}
</script>
</head>

<body class="" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="https://trxiv.yorks0n.com" accesskey="h" title="TRxiv2 (Alt + H)">TRxiv2</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
        </ul>
    </nav>
</header>
<main class="main">
<article class="post-single">
  <header class="post-header">
    
    <h1 class="post-title">
      health informatics
    </h1>
    <div class="post-meta"><span>updated on October 29, 2023</span>

</div>
  </header> 
  <div class="post-content"><div class="accordion accordion-flush" id="accordionFlushExample"><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.10.22.23297277">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.10.22.23297277" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.10.22.23297277">
        <p class="paperTitle">DiabetIA: Building Machine Learning Models for Type 2 Diabetes Complications</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.10.22.23297277" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.10.22.23297277" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Tripp, J.; Santana-Quinteros, D.; Perez-Estrada, R.; Rodriguez-Moran, M. F.; Arcos-Gonzalez, C.; Mercado-Rios, J.; Cristobal-Perez, F.; Hernandez-Martinez, B. R.; Nava-Aguilar, M. A.; Gonzalez-Arroyo, G.; Salazar-Fernandez, E. P.; Quiroz-Armada, P. S.; Cortes-Vieyra, R.; Noriega-Cisneros, R.; Zinzun-Ixta, G.; Maldonado-Pichardo, M. C.; Flores-Alvarez, L. J.; Reyes-Granados, S. C.; Chagolla-Morales, R.; Paredes-Saralegui, J. G.; Flores-Garrido, M.; Garcia-Velazquez, L. M.; Figueroa-Mora, K. M.; Gomez-Garcia, A.; Alvarez-Aguilar, C.; Lopez-Pineda, A.</p>
        <p class="info">Score: 3.0, Published: 2023-10-23 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.10.22.23297277' target='https://doi.org/10.1101/2023.10.22.23297277'> 10.1101/2023.10.22.23297277</a></p>
        <p class="abstract">BackgroundArtificial intelligence (AI) models applied to diabetes mellitus research have grown in recent years, particularly in the field of medical imaging. However little work has been done exploring real-world data (RWD) sources such as electronic health records (EHR) mostly due to the lack of reliable public diabetes databases. However, with more than 500 million patients affected worldwide, complications of this condition have catastrophic consequences. In this manuscript we aim to first extract, clean and transform a novel diabetes research database, DiabetIA, and secondly train machine learning (ML) models to predict diabetic complications.

MethodsIn this study, we used observational retrospective data from the Mexican Institute for Social Security (IMSS) extracting and de-identifying EHR data for almost 2 million patients seen at primary care facilities. After applying eligibility criteria for this study, we constructed a diabetes complications database. Next, we trained naive Bayesian models with various subsets of variables, including an expert-selected model.

ResultsThe DiabetIA database is composed of 136,674 patients (414,770 records and 447 variables), with 33,314 presenting diabetes (24.3%). The most frequent diabetic complications were diabetic foot with 2,537 patients, nephropathy with 1,914 patients, retinopathy with 1,829 patients, and neuropathy with 786 patients. These complications were accurately predicted by the Gaussian naive Bayessian models with an average area under the curve AUC of 0.86. Our expert-selected model, achieved an average AUC of 0.84 with 21 curated variables.

ConclusionOur study offers the largest longitudinal research database from EHR data in Latin America for research. The DiabetIA database provides a useful resource to estimate the burden of diabetic complications on healthcare systems. Machine learning models can provide accurate estimations of the total cases presented in medical units. For patients and their clinicians, it is imperative to have a way to calculate this risk and start clinical interventions to slow down or prevent the complications of this condition.

Brief descriptionThe study centers on establishing the DiabetIA database, a substantial repository encompassing de-identified electronic health records from 136,674 patients sourced from primary care facilities within the Mexican Institute for Social Security (IMSS). Our efforts involved curating, cleansing, and transforming this extensive dataset, and then employing machine learning models to predict diabetic complications with high accuracy.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.10.26.23297599">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.10.26.23297599" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.10.26.23297599">
        <p class="paperTitle">Clinical performance of automated machine learning: a systematic review</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.10.26.23297599" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.10.26.23297599" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Thirunavukarasu, A. J.; Elangovan, K.; Gutierrez, L.; Hassan, R.; Li, Y.; Tan, T. F.; Cheng, H.; Teo, Z. L.; Lim, G.; Ting, D. S. W.</p>
        <p class="info">Score: 1.2, Published: 2023-10-26 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.10.26.23297599' target='https://doi.org/10.1101/2023.10.26.23297599'> 10.1101/2023.10.26.23297599</a></p>
        <p class="abstract">Introduction Automated machine learning (autoML) removes technical and technological barriers to building artificial intelligence models. We aimed to summarise the clinical applications of autoML, assess the capabilities of utilised platforms, evaluate the quality of the evidence trialling autoML, and gauge the performance of autoML platforms relative to conventionally developed models, as well as each other. Methods This review adhered to a PROSPERO-registered protocol (CRD42022344427). The Cochrane Library, Embase, MEDLINE, and Scopus were searched from inception to 11 July 2022. Two researchers screened abstracts and full texts, extracted data and conducted quality assessment. Disagreement was resolved through discussion and as-required arbitration by a third researcher. Results In 82 studies, 26 distinct autoML platforms featured. Brain and lung disease were the most common fields of study of 22 specialties. AutoML exhibited variable performance: AUCROC 0.35-1.00, F1-score 0.16-0.99, AUCPR 0.51-1.00. AutoML exhibited the highest AUCROC in 75.6% trials; the highest F1-score in 42.3% trials; and the highest AUCPRC in 83.3% trials. In autoML platform comparisons, AutoPrognosis and Amazon Rekognition performed strongest with unstructured and structured data respectively. Quality of reporting was poor, with a median DECIDE-AI score of 14 of 27. Conclusions A myriad of autoML platforms have been applied in a variety of clinical contexts. The performance of autoML compares well to bespoke computational and clinical benchmarks. Further work is required to improve the quality of validation studies. AutoML may facilitate a transition to data-centric development, and integration with large language models may enable AI to build itself to fulfil user-defined goals.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.10.25.23297563">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.10.25.23297563" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.10.25.23297563">
        <p class="paperTitle">Toward AI-Guided Smoking Cessation: Individualized Nicotine Addiction Modeling Using Gaussian Processes</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.10.25.23297563" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.10.25.23297563" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Chari, A.</p>
        <p class="info">Score: 1.2, Published: 2023-10-27 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.10.25.23297563' target='https://doi.org/10.1101/2023.10.25.23297563'> 10.1101/2023.10.25.23297563</a></p>
        <p class="abstract">Cigarette smoking remains the leading cause of preventable disease and death in the United States, accounting for nearly half a million deaths annually. Given the recent rise of artificial intelligence in healthcare applications, computational assessment of smoking behaviors is a promising direction. In this study, we aim to recognize and classify addiction patterns in individual smokers&#39; daily usage based on time series data. To this end, we leverage Gaussian process modeling to iteratively learn a function that defines a smoker&#39;s behavior as usage data is accumulated. Namely, we aim to learn weekly periodic trends in usage, and then utilize the model to predict future trends. We demonstrate that the outputted predictions resemble the actual data well and that these informed forecasts significantly outperform those of a naive prediction model with respect to accuracy. Finally, we propose strategies for utilizing these predictions for goal-setting as part of a computer-supervised gradual cessation program.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2022.12.07.22283216">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2022.12.07.22283216" aria-expanded="false" aria-controls="flush-collapse10.1101/2022.12.07.22283216">
        <p class="paperTitle">FDA approved Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices: An updated landscape</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2022.12.07.22283216" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2022.12.07.22283216" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Joshi, G.; Jain, A.; Araveeti, S. R.; Adhikari, S.; Garg, H.; Bhandari, M.</p>
        <p class="info">Score: 3.0, Published: 2023-10-23 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2022.12.07.22283216' target='https://doi.org/10.1101/2022.12.07.22283216'> 10.1101/2022.12.07.22283216</a></p>
        <p class="abstract">As artificial intelligence (AI) has been highly advancing in the last decade, machine learning (ML) enabled medical devices are increasingly used in healthcare. In this article, we performed comprehensive analysis of FDA approved Artificial Intelligence and Machine Learning (AI/ML)- Enabled Medical Devices and offer an in-depth analysis of clearance pathways, approval timeline, regulation type, medical specialty, decision type, recall history etc. We found a significant surge in approvals since 2018, with clear dominance of radiology specialty in the application of machine learning tools, attributed to the abundant data from routine clinical data. The study also reveals a reliance on the 510(k)-clearance pathway, emphasizing its basis on substantial equivalence and often bypassing the need for new clinical trials. Also, it notes an underrepresentation of pediatric- focused devices and trials, suggesting an opportunity for expansion in this demographic. Moreover, the geographical limitation of clinical trials, primarily within the United States, points to a need for more globally inclusive trails to encompass diverse patient demographics. This analysis not only maps the current landscape of AI/ML-Enabled Medical Devices but also pinpoints trends, potential gaps, and areas for future exploration, clinical trial practices, and regulatory approaches.</p>
      </div>
    </div>
  </div>
</div>









<script src="/js/bundle.min.js" defer></script>



  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>
  </footer>
</article>
    </main>
    
<footer class="footer">
    <span>&copy; 2023 <a href="https://trxiv.yorks0n.com">TRxiv2</a></span>
    <span>
        · Made by Yorkson
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
